Milczek T - Search Results

1

Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.

Milczek T, Klasa-Mazurkiewicz D, Emerich J, Kobierski J. Milczek T, et al. Acta Obstet Gynecol Scand. 2009;88(4):463-7. doi: 10.1080/00016340902777525. Acta Obstet Gynecol Scand. 2009. PMID: 19235559 Free article.

2

[Evaluation of the effectiveness of second-line intraperitoneal chemotherapy for patients with ovarian cancer].

Milczek T, Emerich J, Debniak J, Klasa-Mazurkiewicz D. Milczek T, et al. Ginekol Pol. 2002 Nov;73(11):1027-33. Ginekol Pol. 2002. PMID: 12722394 Polish.

3

Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients.

Klasa-Mazurkiewicz D, Narkiewicz J, Milczek T, Lipińska B, Emerich J. Klasa-Mazurkiewicz D, et al. Among authors: milczek t. Gynecol Oncol. 2009 Apr;113(1):91-8. doi: 10.1016/j.ygyno.2008.12.038. Epub 2009 Feb 3. Gynecol Oncol. 2009. PMID: 19193429

4

Analysis of the results and long-term follow-up of second-look laparotomy in advanced ovarian cancer.

Sawicki S, Wydra D, Kobierski J, Milczek T, Emerich J. Sawicki S, et al. Among authors: milczek t. Eur J Gynaecol Oncol. 2009;30(4):422-5. Eur J Gynaecol Oncol. 2009. PMID: 19761136

5

Regimens with intraperitoneal cisplatin plus intravenuous cyclophosphamide and intraperitoneal carboplatin plus intravenuous cyclophosphamide are equally effective in second line intraperitoneal chemotherapy for advanced ovarian cancer.

Milczek T, Klasa-Mazurkiewicz D, Sznurkowski J, Emerich J. Milczek T, et al. Adv Med Sci. 2012 Jun 1;57(1):46-50. doi: 10.2478/v10039-012-0002-1. Adv Med Sci. 2012. PMID: 22430042

6

[Comparison of quality of life in patients with advanced ovarian cancer treated with intraperitoneal or intravenous cisplatin and cyclophosphamide as a second line of therapy].

Majdak E, Krasińska L, Mielcarek P, Kobierski J, Kozaka J, Milczek T, Emerich J. Majdak E, et al. Among authors: milczek t. Ginekol Pol. 2002 Nov;73(11):1096-102. Ginekol Pol. 2002. PMID: 12722405 Polish.

7

[Evaluation of surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].

Emerich J, Milczek T, Debniak J, Majdak E. Emerich J, et al. Among authors: milczek t. Ginekol Pol. 2002 Nov;73(11):1103-8. Ginekol Pol. 2002. PMID: 12722406 Polish.

8

[Surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].

Milczek T, Emerich J, Klasa-Mazurkiewicz D. Milczek T, et al. Ginekol Pol. 2003 Sep;74(9):817-23. Ginekol Pol. 2003. PMID: 14674130 Polish.

9

Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.

Majdak EJ, Debniak J, Milczek T, Cornelisse CJ, Devilee P, Emerich J, Jassem J, De Bock GH. Majdak EJ, et al. Among authors: milczek t. Cancer. 2005 Sep 1;104(5):1004-12. doi: 10.1002/cncr.21276. Cancer. 2005. PMID: 16047333 Free article.

10

[The correlation between prognostic factors and outcome of second look laparotomy in ovarian cancer].

Dudziak M, Klasa-Mazurkiewicz D, Milczek T, Zmudzińska E, Emerich J. Dudziak M, et al. Among authors: milczek t. Ginekol Pol. 2005 Jul;76(7):555-63. Ginekol Pol. 2005. PMID: 16363382 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters